期刊文献+

Nucleostemin基因荧光真核表达载体构建及表达特性 被引量:3

Construction and expression of nucleostemin gene fluorescent eukaryotic cell expression vector
原文传递
导出
摘要 目的:构建Nucleostemin(NS)基因真核表达载体,并在COS-7细胞中表达。方法:设计引物在肺癌细胞株(LTEP-a-2)中扩增NS全长cDNA片段,插入pMD-18T质粒中得pMD-18T-NS载体,并测序;再将pMD-18T-NS质粒经酶切后导入真核表达载体pcDNA3.1(+)-GFP质粒中,构建pcDNA3.1(+)-GFP-NS载体,并检测其真核表达情况。结果:经RT-PCR扩增得到1650bp的全长NScDNA片段,酶切及测序后鉴定证明pMD-18T-NS构建成功。pcDNA3.1(+)-G-FP-NS载体转染COS-7细胞经蛋白印迹及激光共聚焦显微镜检测显示,该GFP-N-S融合基因在COS-7细胞中获得较好表达。转染后见该基因定位于核仁,细胞逐渐失去黏附贴壁的特性,细胞的增殖受阻;稳定表达(4~20周)后,细胞形态发生改变,体积增大,核增多,细胞成瘤细胞样改变。结论:成功构建pcDNA3.1(+)-GF-P-NS真核表达载体,并在COS-7细胞中有效表达;NS基因在COS-7发生瘤样改变过程中发挥着重要作用,可能与肿瘤发生密切相关。 OBJECTIVE:To construct nucleostemin(NS)gene fluorescent eukaryotic cell expression vector,and detect its expression in a eukaryotic cell COS-7.METHODS:The full-length NS cDNA fragment of lung cancer cell line(LTEP-a-2)was synthesized by RT-PCR,the fragment was linked up with pMD-18T vector by co-adhesive end restriction,named pMD-18T-NS vector and sequenced,and then NS cDNA fragment obtained from pMD-18T-NS vector was ligated with pcDNA3.1(+)-GFP to construct fluorescent eukaryotic cell expression vector pcDNA3.1(+)-GFP-NS,after being identified and expressed in COS-7 cells.RESULTS:A 1 650 bp fragment of the full-length NS cDNA was amplified by RT-PCR,using digestion and sequencing to prove successful construction of pMD-18T-NS vector.The results revealed that in COS-7 cells the GFP-NS fusion gene was expressed better after pcDNA3.1(+)-GFP-NS vector transfect COS-7 cells.By Western blot and laser scanning confocal microscope,it was seen that the transfected gene located in the nucleolus,and the cells gradually lose the characteristics of adherent adhesion,and cell proliferation blocked.A tumor-like change,such as the changes in cell morphology,increased volume and nuclear number,was find after stable expression of NS(4-20 weeks).CONCLUSIONS:The pcDNA3.1(+)-GFP-NS eukaryotic expression vector is constructed successfully and effectively expressed in the COS-7 cells.NS might be one of the factors playing important roles during tumour genesis.
出处 《中华肿瘤防治杂志》 CAS 2009年第20期1529-1533,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 江苏省自然科学基金(BK2007072) 江苏省卫生厅"科教兴卫工程""医学重点学科""实验诊断学"开放性课题(XK200723/WKF0809)
关键词 NUCLEOSTEMIN 肿瘤 真核表达 nucleostemin tumour eukaryotic expression
  • 相关文献

参考文献5

二级参考文献45

  • 1张翠娟,周庚寅,李丽,喻芳,孙妍琳,马超.葡萄籽多酚对人乳腺癌细胞株MCF-7/ADR的体内外耐药逆转作用[J].山东大学学报(医学版),2004,42(6):640-642. 被引量:3
  • 2王鲁平,陈健,宁浩勇,刘光,丁华野,虞积耀,Charles B,Underhill,张鲁榕.TR6在人乳腺癌中的功能、表达和意义[J].诊断病理学杂志,2005,12(2):133-136. 被引量:12
  • 3Bai C, Connolly B, Metzker M L, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster[J]. Proc Natl Acad Sci U S A, 2000, 97(3) :1230-1235.
  • 4Pitti R M, Marsters S A, Lawrence D A, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer[J]. Nature, 1998, 396(6712):699-703.
  • 5Yulian Wu, Bing Han, Hongwei Sheng. Clinical significance of detecting elevated serum DcR3/DCR3/M68 in malignant tumor patients[J]. Int J Cancer,2003, 105(5) :724-732.
  • 6Ohshima K, Haraoka S, Sugihara M, et al. Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas[J]. Cancer Lett, 2000, 160(1):89-97.
  • 7Wu Y L, Yu J X, Shen H W, et al. Clinical significance and correlation between elevated serum DCR3 and lympho-metastasis in gastriccancer[J]. Zhonghua Wai Ke Za Zhi, 2003, 41(12): 928-931.
  • 8ligand mediate Connolly K, Cho Y H, Duan R, et al. In vivo inhibition of Fas d killing by DCR3, a Fas ligand decoy receptor [J]. J Pharmacol Exp Ther,2001,298(1):25-33.
  • 9Timmer T, de Vries E G, de Jong S. Fas receptor-mediated apoptosis: a clinical application? [J]. J Pathol ,2002, 196(2) :125- 134.
  • 10Yu K Y, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (DCR3) suppresses LIGHT-mediated apoptosis[J]. J Biol Chem, 1999, 274 (20): 13733-13736.

共引文献89

同被引文献38

  • 1钱晖,许文荣,王文兵,韩崇旭,郝顺祖,朱伟,孙晓春,胡嘉波,黄诒森.骨髓间充质干细胞和部分肿瘤细胞中Nucleostemin基因的表达[J].中国生物化学与分子生物学报,2005,21(1):8-12. 被引量:36
  • 2张琼,张昌菊.P120ctn及相关蛋白在宫颈鳞癌中的表达及生物学意义[J].山东医药,2007,47(16):20-21. 被引量:2
  • 3Liang P,Pardee A B. Differntial display of eukaryotic messenger RNA by means of the Polymerase Chain Reaction[J]. Science, 1992,257(5072) :967 -971.
  • 4Tsai RY, McKay RD. A nueleolar mechanism controlling cell proliferation in stem cells and cancer cellsEJ~. Genes, 2002,16 (23) : 2991-3003.
  • 5Normile D. Cell proliferation : Common control for cancer, stem cells[J].Science, 2002, 298(5600): 1869-1870.
  • 6Bernnardi R, Pandolefi PP. The nucleolus:at the stemof immor- tality[J]. Nat Med, 2003,9 (1) : 24-25.
  • 7Kafienah W, Mistry S, Hollander AP. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow [J]. Stem Cells, 2006,24(4) : 1113-1120.
  • 8Liu Y,Dong QZ,Zhao Y,et al.P120-catenin isoforms 1Aand3Adifferently affect invasion and proliferation of lung cancercells[J].Exp Cell Res,2009,315(5):890-898.
  • 9Liu Y,Li QC,Miao Y,et al.Ablation of p120-catenin enhancesinvasion and metastasis of human lung cancer cells[J].CancerSci,2009,100(3):441-448.
  • 10Ireton RC,Davis MA,van Hengel J,et al.A novel role for p120cate-nin in E-cadherin function[J].J Cell Biol,2002,159(3):465-476.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部